16 February 2024>: Clinical Research
Factors Influencing Discontinuation of Clazosentan Therapy in Elderly Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Study from a Japanese Single Center
Tatsushi Mutoh 1ABCDEF* , Hiroaki Aono 1BDE , Wataru Seto 2BE , Takehiro Kimoto 2BE , Ryota Tochinai 3DE , Junta Moroi 1BE , Tatsuya Ishikawa 1DEDOI: 10.12659/MSM.943303
Med Sci Monit 2024; 30:e943303
Figure 1 An illustrative case of 81-year-old woman with SAH caused by ruptured aneurysm in right middle cerebral artery. (A) Non-contrast CT images on admission (upper panel) and postoperative day 1 (lower panel). (B) Volume-rendering enhanced CT angiography images on admission shows a large aneurysm in the right middle cerebral artery (yellow arrow) compatible with the clot distribution. (C) Serial changes of chest X-ray images before and after clazosentan therapy. CT – computed tomography; SAH – subarachnoid hemorrhage.